Cargando...

4CPS-037 Analysis of usage profile, effectiveness and safety of alirocumab in a tertiary hospital

BACKGROUND: Hypercholesterolaemia is a common and growing health problem, above all in developed countries, which can cause serious consequencies in patients who suffer from it. Alirocumab is a monoclonal antibody that blocks a protein called PCSK9 and prevents LDL cholesterol receptors being absorb...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Hosp Pharm
Main Authors: Garcia, C Mondelo, Bargiela, N Fernández, Olivera, C Fernández, Filgueiras, J Balea, Arufe, V Giménez, Herranz, MI Martín
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Group 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535505/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.128
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!